NASDAQFinancialsBanks - RegionalSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflowThree key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Execute share buyback plan of up to 5% of shares | It has a clear plan to return cash to shareholders with a share buyback program. | Intact | No meaningful buybacks executed by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextMaintained consistent dividend payout in 2 of last 2 quarters with $0.09 per share declared and paid in both 2026-Q1 and 2026-Q2. This steady dividend reflects management’s commitment to returning capital to shareholders. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 16–Oct 15 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Oct 28, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a stable financial institution with a focus on operational efficiency and consistent dividends. The current thesis state is intact, supported by strong recent financial performance.
The market appears to price LSBK as relatively cheap compared to its peers, with a low fragility tier indicating stability. Expectations seem to reflect a cautious outlook, given the sector headwinds.
Management is on track with priorities such as optimizing the balance sheet and improving operational efficiency. Recent financial results show strong performance, but loan growth and deposit management need to be monitored closely.
Key factors for the future include management's ability to maintain guidance and the performance of sector bellwethers. Additionally, changes in interest rates by the Fed could significantly impact LSBK and its peers.
Overall, LSBK's fundamentals are solid, but the investment's success will depend on external sector dynamics and management execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain dividend payout at $0.09 per share | Lake Shore Bancorp keeps paying a steady dividend of $0.09 per share. | Intact | dividend per share falls below $0.09 in any quarter of 2026 | Dividend per share: $0.09 per share FY2026-Q2; GAAP. Published target: >= $0.09 per share. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 11, 20260.09 USD/share · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b5671404-6e28-4376-b04f-4b4865e94108. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextMaintained consistent dividend payout in 2 of last 2 quarters with $0.09 per share declared and paid in both 2026-Q1 and 2026-Q2. This steady dividend reflects management’s commitment to returning capital to shareholders. Delivery assessment Oct 15, 2026 |
EPS grows to at least $0.97 in 2026 | The company shows stable earnings with EPS guidance near $0.97 for 2026. | Intact | EPS falls below $0.97 in FY26 | Diluted EPS: $0.29 per share FY2026-Q2; GAAP. Published target: >= $0.97 per share. Target period is not explicitly aligned with this observation. Source published Aug 11, 20260.29 USD/share · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b5671404-6e28-4376-b04f-4b4865e94108. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.